查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1247461

2023-2030 年术前计划软件的全球市场

Global Preoperative Surgical Planning Software Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球术前规划软件市场预计将出现有利可图的增长，到 2022 年将达到 9720 万美元，到 2030 年将达到 1.5787 亿美元。 在预测期内（2023-2030 年），该市场的复合年增长率为 6.3%。

术前规划软件可帮助外科医生为患者确定最佳治疗和手术方案。 将您患者的历史数据、诊断数据和其他重要数据输入该软件，该软件将为您的患者提供理想的手术方式。 术前规划软件提供简化的手术方案，以提高手术成功率。 该软件用于骨科手术、牙科手术、神经外科和重建手术等手术。 Medtronic Plc、Stryker Corporation、WishBone Medical Inc.、Zimmer Biomet、Siemens AG、Brainlab AG 是市场上的主要参与者。

市场动态

骨科手术越来越受欢迎

在预测期内，对术前规划软件的需求不断增长，正在推动全球市场的增长。 由于全球骨科手术数量的增加，术前计划软件市场预计将出现高速增长。 例如，根据美国骨科医师学会的数据，美国每年大约进行一百万次膝关节和髋关节置换手术。 由于骨骼和肌肉疼痛问题日益严重，对髋关节和膝关节置换术等骨科手术的需求量很大。 因此，上述因素正在推动骨科领域的市场主导地位。

产品召回的增加预计将阻碍市场增长

术前手术计划软件是一种复杂的软件，它使用许多不同类型的组件，并且可能会因其复杂性而开始出现故障。 由于这些复杂性，软件通常无法提供术前计划协议。 例如，2020 年 2 月，美国食品和药物管理局 (U.S.FDA) 报告召回 Zimmer Biomet 的 ROSA Brain 3.0。 该软件无法提供足够的患者横截面图像。 使用 ROSA Brain 软件时，图像无法在 2D 和 3D 视图中正确显示。 错误生成的数据很可能导致错误的手术计划。

COVID-19 影响分析

除了 COVID 之前、COVID 和 COVID 之后的情况外，COVID-19 分析还包括价格动态（包括与 COVID 之前的情况相比，大流行期间和之后的价格变动）、供需范围（交易限制） 、封锁以及随后由于问题导致的供需变化）、政府举措（政府机构为振兴市场、部门和行业而采取的举措）、製造商的战略举措（製造商为缓解 COVID 问题而采取的举措）。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 片段类型
  • 按应用程序摘录
  • 最终用户的片段
  • 区域摘要

第 4 章动力学

  • 影响因子
    • 司机
      • 技术日新月异
      • 骨科手术领域的受伤和手术数量增加
    • 约束因素
      • 监管机构召回产品的数量增加
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按类型

  • 基于云
  • 本地

第八章应用

  • 骨科
  • 骨科
  • 神经外科
  • 牙科/牙齿矫正
  • 其他

第 9 章最终用户

  • 医院
  • 门诊手术系统
  • 专业中心
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场分析/份额分析
  • 併购分析

第12章公司简介

  • 美敦力公司
    • 公司简介
    • 产品组合和说明
    • 财务摘要
    • 主要发展
  • Stryker Corporation
  • WishBone Medical Inc.
  • Zimmer Biomet
  • Siemens AG
  • Brainlab AG
  • GE Healthcare
  • Renishaw Plc
  • mediCAD Hectec GmbH
  • Peek Health S.A.

第13章 附录

简介目录
Product Code: HCIT1348

Market Overview

The global preoperative surgical planning software market reached US$ 97.20 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 157.87 million by 2030. The market is growing at a CAGR of 6.3% during the forecast period (2023-2030).

Preoperative surgical planning software provides helps surgeons to decide the best treatment and surgical options for the patients. When the software is fed with the patient's historical data, diagnostics data, and other essential data, the software gives an ideal surgical approach to the patient. The preoperative surgical planning software gives a streamlined surgical protocol to increase the success rate of the surgery. This software is used for surgeries like orthopedic surgeries, dental surgery, neuro-surgery, reconstruction surgery, and others. Medtronic Plc, Stryker Corporation, WishBone Medical Inc., Zimmer Biomet, Siemens AG, and Brainlab AG are the major players in the market.

Market Dynamics

The increasing prevalence of orthopedic surgeries

The growing demand for preoperative surgical planning software is driving growth in the global market over the forecast period. The preoperative surgical planning software market is expected to witness high growth owing to the increasing number of orthopedic surgeries across the globe. For instance, according to the American Board of Orthopedic Surgery, around 1 million knee and hip arthroplasties were performed in the U.S. every year. Orthopedic surgeries like hip and knee replacement/arthroplasty are highly in demand owing to increasing bone and muscle pain problems. Therefore, the above-mentioned factors help the orthopedic surgery segment to dominate the market.

Rising product recalls are expected to hinder the market growth

Preoperative surgical planning software is a complex software that uses various types of components that may start malfunctioning because of complexities. Owing to these complexities the software often fails to provide the surgical preplanning protocol. For instance, in February 2020, the U.S. Food and Drug Administration (U.S.FDA), reported the recall of ROSA Brain 3.0 manufactured by Zimmer Biomet. The software was not able to provide the proper cross-sectional images of the patients. The images were not properly displayed in two and three-dimensional views when using ROSA Brain software. The wrong-generated data was very likely to give incorrect surgery planning.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global preoperative surgical planning software market is segmented based on type, application, end user, and region.

On basis of the Type, Orthopedic surgery is expected to hold the largest share

Cloud-based, a type segment of preoperative surgical planning software, dominates the global market due to its versatility, cost-effectiveness, and high demand in the surgical market. The increasing product launches of cloud-based software are expected to accelerate the preoperative surgical planning software market over the forecast period. For instance, in April 2021, Corin Group launched the new OPSInsight preoperative planning software for total hip arthroplasty (THA). The product is a cloud-based platform using Corin's next-generation Optimized Positioning System (OPS) technology. These advantages of cloud-based software highly contribute to the factors that help the product segment to dominate the market.

Geographical Analysis

Growing demand for preoperative surgical planning software in Asia Pacific

The growing demand for preoperative surgical planning software in developing countries, especially in Asia-Pacific, creates opportunities for manufacturers to expand their operations in these regions. The region has many manufacturers and its strong economic growth has led to increased demand by the hospitals and ambulatory surgical centers that are highly technology equipped thereby boosting the demand for preoperative surgical planning software. The region's rapidly growing population and urbanization, leading to increased demand for streamlined surgical procedures, is also a factor. Growing awareness about the benefits and AI integration contributes to the market's growth in the region. Furthermore, the above-stated factors depict Asia-Pacific's fastest growth in the market.

Competitive Landscape

The major global players in the market include Medtronic Plc, Stryker Corporation, WishBone Medical Inc., Zimmer Biomet, Siemens AG, Brainlab AG, GE Healthcare, Renishaw Plc, mediCAD Hectec GmbH, and Peek Health S.A.

Why Purchase the Report?

  • To visualize the global preoperative surgical planning software market segmentation based on type, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of preoperative surgical planning software market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global preoperative surgical planning software market report would provide approximately 61 tables, 58 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rapid growth in technological advancements
      • 4.1.1.2. Increasing cases of orthopedic injuries and related surgeries
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. Rising number of product recalls by regulatory authorities
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Cloud-based*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. On-premise

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic Surgery*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedic Surgery
  • 8.4. Neurosurgery
  • 8.5. Dental and Orthodontics
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Systems
  • 9.4. Specialty Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Stryker Corporation
  • 12.3. WishBone Medical Inc.
  • 12.4. Zimmer Biomet
  • 12.5. Siemens AG
  • 12.6. Brainlab AG
  • 12.7. GE Healthcare
  • 12.8. Renishaw Plc
  • 12.9. mediCAD Hectec GmbH
  • 12.10. Peek Health S.A.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us